Ambereen K. Mehta, MD, MPH, FAAHPM is the Interim Medical Director of the Palliative Care Program at Johns Hopkins Bayview Medical Center and an Associate Professor of Palliative Care in the Departments of Medicine and Neurology at the Johns Hopkins School of Medicine. She developed the specialty palliative care program in the Johns Hopkins Center for Specialty ALS Care.  

She leads multiple studies as part of the ALS Clinical Trials Unit including a study of psilocybin for patients with ALS and depression and their caregivers funded by the Department of Defense. She has published numerous studies in high impact peer-reviewed journals on increasing access to specialty palliative care including education for neurologists and improving quality of life for people with neurological illnesses, specifically those living with ALS. 

She is President-elect of the International Neuropalliative Care Society (INPCS), has served as co-chair of the Northeast ALS Consortium Palliative Subcommittee, co-leads the INPCS ALS Working Group, and is an ALS Association Care Services Committee member. She is an Associate Editor of the Journal of Pain and Symptom Management, the official journal of the American Academy of Hospice and Palliative Medicine (AAHPM). She is the past Chair of the INPCS Strategic Communications Committee and the AAHPM Neuropalliative Special Interest Group.  

She has received awards for education including the 2020 UCLA Hospice and Palliative Medicine Fellowship Faculty Award Excellence in Education Award and the 2022 Inaugural INPCS Tara Cook Award for Innovation in Neuropalliative Education. She is a content expert for the Muscular Dystrophy Association, Roon, and Northeast ALS Consortium.